All articles
Site OperationsNovember 8, 2026·3 min read

The Real Cost of a Screen Failure at Your Site

Screen failures are the biggest source of unreimbursed labor at most research sites — and a large share of them are preventable. Here's how to calculate the real cost and push disqualifying answers earlier in the funnel.

By Trialflow Team

Screen failures are the most normalized loss in clinical research. Everyone expects them. Budgets nominally cover them. And yet, for most sites, screen failures are the single largest source of unreimbursed labor on the books.

It's worth doing the arithmetic honestly, because once you see the real cost, you make different decisions about pre-screening.

What a screen failure actually costs

Start with the visit itself. A screening visit typically consumes coordinator time for consent, medical history, vitals, ECG, and lab draw — commonly two to four hours of hands-on work for a moderately complex protocol. Add physician time for history and eligibility sign-off. Add lab processing and shipping. Add the data entry that follows, plus the query resolution that follows the data entry.

Then add the invisible layers:

  • Chart review and phone pre-screening before the visit was ever scheduled
  • Scheduling and rescheduling labor, including no-show recovery
  • Exam room occupancy that another study couldn't use
  • Participant stipend and travel reimbursement, often paid regardless of outcome
  • Regulatory documentation for a subject who never enrolled

Sponsors reimburse screen failures at a fraction of a completed screening visit, and often cap the number they will pay for. Beyond that cap, every failure is pure site expense. In most site budgets, the gap between true cost and reimbursement widens exactly when your failure rate is highest — which is to say, when you can least afford it.

The failure rate you choose

Here's the uncomfortable part: a large share of screen failures are decisions your site made, not facts the protocol imposed.

Failures split roughly into three buckets. Protocol-inherent failures come from criteria you cannot assess until the lab returns — HbA1c windows, viral load, imaging findings. You'll absorb those; they're the cost of doing the study. Preventable failures come from criteria you could have checked earlier: concomitant medications, washout periods, prior therapy, BMI, age windows, distance from site. Process failures come from expired labs, missed windows, incomplete source, or a participant who lost interest between consent and procedure.

Only the first bucket is unavoidable. The other two are operational.

Pushing the decision earlier

The economic goal is simple: move every disqualifying answer as early in the funnel as possible, where it costs minutes instead of hours.

  1. Rank your exclusion criteria by frequency, not by protocol order. After ten screen failures, you know which three criteria are doing the work. Put those at the top of your phone script.
  2. Pull records before you schedule, not after. A fifteen-minute chart review that catches an exclusionary medication saves a four-hour visit.
  3. Ask the hard questions on the phone. Coordinators soften questions about substance use, prior biologics, or travel ability because they don't want to lose a candidate. You're not losing them — you're finding out earlier.
  4. Split the screening visit where the protocol allows. Consent and draw labs first; defer imaging, ECG, and physician exam until results return.
  5. Track cost per enrolled, not cost per screened. A channel with a lower failure rate can beat a cheaper channel on total cost.

Negotiate before you sign

During budget negotiation, bring your own historical failure rate for similar protocols and ask for an uncapped screen-failure line, or a rate closer to the full visit value. Sites that can document a defensible rate win this more often than sites that argue from principle. That documentation is also what lets you decline a study whose screening economics never worked in the first place.

Enrolling studies shouldn't be this hard

Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.

Request a Demo